News & Updates

Use of osilodrostat is effective at controlling hypercortisolism in one of three (66.7 percent) patients with adrenal Cushing's syndrome (CS) treated for longer than 4 weeks and in nearly four of five (87.5 percent) individuals treated for more than 12 weeks, a real-world study has shown. It also displays a positive impact on blood pressure and body weight.

In a study presented at ESHRE 2026, a novel, wearable transcutaneous auricular vagus nerve stimulation (taVNS) device alleviates menstrual pain and complications of primary dysmenorrhoea.

The use of combined oral contraceptives, progestogen-only pills, or hormonal intrauterine devices neither protects against nor contributes to the risk of colorectal cancer (CRC) in premenopausal women, according to a study.